Two Sigma Securities LLC Sells 11,642 Shares of Humana Inc. (NYSE:HUM)

Two Sigma Securities LLC cut its position in Humana Inc. (NYSE:HUM - Free Report) by 66.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,781 shares of the insurance provider's stock after selling 11,642 shares during the period. Two Sigma Securities LLC's holdings in Humana were worth $1,467,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in HUM. FPC Investment Advisory Inc. bought a new position in Humana in the 4th quarter worth about $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana in the 4th quarter worth about $30,000. LFA Lugano Financial Advisors SA increased its stake in Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management purchased a new position in shares of Humana in the fourth quarter worth approximately $33,000. Finally, Transce3nd LLC purchased a new position in Humana during the fourth quarter valued at approximately $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Down 0.8 %

HUM traded down $2.13 during trading on Wednesday, reaching $257.23. 1,696,624 shares of the stock traded hands, compared to its average volume of 1,658,510. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The stock's 50-day simple moving average is $266.05 and its two-hundred day simple moving average is $270.76. The stock has a market cap of $31.05 billion, a price-to-earnings ratio of 25.85, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same period last year, the business earned $7.23 earnings per share. The business's revenue was up 8.4% on a year-over-year basis. As a group, equities research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.38%. Humana's payout ratio is 35.58%.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Guggenheim started coverage on shares of Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target for the company. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Truist Financial lifted their price target on shares of Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a report on Friday, April 11th. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Finally, Morgan Stanley lowered their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Seventeen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Humana has a consensus rating of "Hold" and a consensus target price of $284.90.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.